Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Clearwater Analytics’ $1.5 Billion Acquisition of Enfusion
Kirkland & Ellis advised Clearwater Analytics, Goodwin Procter advised Enfusion, and Dechert advised the Special Committee of Enfusion on the deal. Clearwater Analytics (NYSE: CWAN), a...
Renesas’ $339 Million Acquisition of Transphorm
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Marlin Equity’s Acquisition of Meltwater N.V.
AKD, Wiersholm, Houthoff, Schjødt, DLA Piper and Goodwin Procter advised Marlin Equity Partners on the deal, while Freshfields and Thomessen acted for Altor. Marlin Equity Partners,...
Thoma Bravo’s AUD $1.055 Billion Acquisition of Nearmap
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
KVH Industries’ Asset Purchase Agreement with EMCORE Corporation
Goodwin Procter advised KVH Industries on the deal while Pillsbury advised EMCORE Corporation. KVH Industries, Inc. (NASDAQ: KVHI) announced its asset purchase agreement with EMCORE Corporation....
BD’s $1.525 Billion Acquisition of Parata Systems
Goodwin Procter advised Frazier Healthcare Partners on the deal. Frazier Healthcare Partners announced its definitive agreement with BD (Becton, Dickinson and Company) (NYSE: BDX) for BD to...
CSafe Global’s Acquisition of Softbox Systems
Goodwin Procter advised CSafe Global on the deal. CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, announced the completion of its...
EQRx’s Merger with CM Life Sciences III
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
SWORD Health’s $85 Million Series C Funding Round
Goodwin Procter advised SWORD Health on the deal. SWORD Health announced the completion of its $85 million Series C funding round led by General Catalyst. Other participating...
Symphony’s Acquisition of Cloud9 Technologies
Goodwin Procter LLP advised Symphony on the deal while Wilmer Cutler Pickering Hale and Dorr represented Cloud9 Technologies. Symphony announced its acquisition of Cloud9 Technologies. Symphony is...